{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_29", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": ", in \nlate pregnancy may lead to an increased risk for neonatal \ncomplications requiring prolonged hospitalization, \nrespiratory support, and tube feeding, and/or persistent \npulmonary hypertension of the newborn (PPHN). \nMonitor neonates who were exposed to [TRADENAME] in \nthe third trimester of pregnancy for PPHN and drug \ndiscontinuation syndrome [see Data]. \nFDA/CDER/OND/ODEIV/DPMH 28 \n8.1 Pregnancy â€“ Clinical Considerations \nClinical Considerations \nDose Adjustments During Pregnancy and the"}